Bulletin
Investor Alert

Teva Pharmaceutical Industries Ltd. ADR

NYS: TEVA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Nov 25, 2022, 3:51 p.m.

/zigman2/quotes/205657894/composite

$

8.94

Change

+0.07 +0.79%

Volume

Volume 5,109

Quotes are delayed by 20 min

/zigman2/quotes/205657894/composite

Previous close

$ 8.80

$ 8.87

Change

+0.07 +0.80%

Day low

Day high

$8.74

$8.95

Open

52 week low

52 week high

$6.78

$11.34

Open

Insider Actions for Teva Pharmaceutical Industries Ltd. ADR

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
05/10/2018 Bridger Management LLC
Director
250,000   Acquisition at $19.32 per share. 4,830,000
05/09/2018 Bridger Management LLC
Director
500,000   Acquisition at $19.21 per share. 9,605,000

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
0 Sales
0
0
Last 6 months
0 Purchases
0 Sales
0
0
Last 12 months
0 Purchases
0 Sales
0
0

Officers and Executives

Mr. Kåre Schultz
President, Chief Executive Officer & Director
Dr. Eric Drapé
Executive Vice President-Global Operations
Mr. Eli Kalif
Chief Financial Officer & Executive Vice President
Dr. Eric A. Hughes
Chief Medical Officer, Executive VP-Global R&D
Mr. John Nason
President-Biologics Operations
Ms. Hanadi Said
Director-Global Risk Management
Ms. Kathleen Veit
Senior VP-Global Compliance & Ethics Officer
Mr. Mark Sabag
EVP-International Markets Commercial Division
Mr. Brian E. Shanahan
VP & Deputy General Counsel-Transactions
Dr. Sven Dethlefs
Executive VP-North America Commercial Region
Mr. Richard Daniell
Executive VP-European Commercial Division
Mr. Eli Shani
Executive VP-Global Marketing & Portfolio
Mr. Amir Weiss
Chief Accounting Officer & Senior Vice President
Mr. Nir Baron
Chief Internal Auditor & Senior Vice President
Mr. Ran Meir
SVP, Head-Investor Relations & Communications
Ms. Galia Inbar
Chief Human Resources & EVP-Global Communications
Mr. Dov Bergwerk
Secretary & Senior Vice President
Mr. David M. Stark
Chief Legal Officer & Executive Vice President
Mr. Yael Ashman
Senior Director-Investor Relations
Dr. Sol J. Barer
Chairman
Ms. Janet S. Vergis
Independent Director
Dr. Tal Zaks
Independent Director
Mr. Amir Elstein
Independent Director
Mr. Jean-Michael Halfon
Independent Director
Ms. Rosemary A. Crane
Independent Director
Mr. Gerald M. Lieberman
Independent Director
Mr. Roberto Agostino Mignone
Independent Director
Dr. Perry D. Nisen
Independent Director
Mr. Nechemia Jacob Peres
Independent Director
Dr. Ronit Satchi-Fainaro
Independent Director
Link to MarketWatch's Slice.